Pure Global
NCT05819645

Oral Fluid Intake After Extubation

Early Versus Delayed Oral Fluid Intake Initiation (Sipping) After Extubation, Influence on the Feeling of Thirst, Patient Comfort and the Occurrence of Complications.
University Hospital, Motol·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intubation
Drug/Device/Intervention
Fluid intake not as per standard guidlines
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University Hospital, Motol
Location
Prague, Czech
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2023
End date
Feb 01, 2025
Enrollment
160 participants
Primary outcome

Assessment of presence or absence of thirst 120 minutes after extubation

Summary

According to the current guidelines the patient is not allowed to drink any fluid at least 2
 hours after extubation to prevent complications. However there is no evidence in the
 literature to support this approach. Because anaesthetic drugs and their side effects changed
 significantly from their first usage, the investigators can assume that existing approach is
 obsolete and has no place anymore in the modern medicine. Keeping patient n.p.o (nothing per
 os) for 2 hours after extubation may lead to patient´s thirst or other discomfort. The aim of
 the study is to detect whether early oral fluid intake after extubation could lead to safe
 relief of thirst and to better patient´s comfort overall.

ICD-10 classifications
Failed or difficult intubationFailed or difficult intubation during labour and deliveryFailed or difficult intubation during pregnancyFailed or difficult intubation during the puerperiumRespiratory arrest
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05819645
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05819645 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Motol and is currently Recruiting. The study focuses on Intubation. Target enrollment is 160 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.